Pfizer Acquires a Stem-Cell Therapy

Monday, December 21, 2009 - 00:49 in Health & Medicine

Pfizer will have the rights to develop Athersys’s cells to treat inflammatory bowel disease, which is in early human testing.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net